Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints CEO of PrimeVigilance

Dr Jan Petracek to drive pharmacoviglance business

Jan_Petracek_ErgomedErgomed has appointed Dr Jan Petracek the new CEO of its pharmacoviglance business PrimeVigilance.

Dr Petracek was previously CEO of European PharmInvent Services, which Ergomed acquired in 2016 and subsequently integrated into PrimeVigilance, and prior to that he served at the likes of MediWound and Vertext Pharmaceuticals.

Dr Miroslav Reljanovic, CEO of Ergomed, said: “We are fortunate to have in the wings a replacement CEO of the calibre of Dr Jan Petracek.

“As founder of PharmInvent and former regulator at EMA, his unique combination of entrepreneurship and specialist pharmacoviglance expertise will serve to drive forward our pharmacoviglance businesses.”

Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition period.

26th April 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics